2023 financial reports - Robuta Search

https://www.education.gov.au/higher-education-publications/resources/finance-2023-financial-reports-higher-education-providers Finance 2023: Financial Reports of Higher Education Providers - Department of Education, Australian... Financial information for the 2023 year including financial performance, financial position and cash flows for higher education providers derived from... 2023 financial reports higher education finance providers department https://www.bookingholdings.com/press-releases/booking-holdings-reports-financial-results-for-third-quarter-2023/ Booking Holdings Reports Financial Results for Third Quarter 2023 - Booking Holdings booking holdings financial results third quarter reports 2023 https://www.biospace.com/nextcure-provides-business-update-and-reports-first-quarter-2023-financial-results NextCure Provides Business Update and Reports First Quarter 2023 Financial Results - BioSpace May 5, 2023 - NextCure, Inc., a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and... business update https://www.biospace.com/singular-genomics-reports-recent-highlights-and-first-quarter-2023-financial-results Singular Genomics Reports Recent Highlights and First Quarter 2023 Financial Results - BioSpace May 10, 2023 - Singular Genomics Systems, Inc., a company leveraging novel next-generation sequencing and multiomics technologies to empower researchers and clinicians,... recent highlights https://www.newswire.ca/news-releases/martello-reports-financial-results-for-the-second-quarter-of-fiscal-2023-853458566.html Martello Reports Financial Results for the Second Quarter of Fiscal 2023 Vantage DX users more than doubled in the first half of fiscal 2023 compared to Q4 FY22 as the Company continues to see market adoption of the... financial results for the second quarter martello reports https://www.jll.com/en-belux/newsroom/jll-reports-financial-results-for-second-quarter-2023 JLL Reports Financial Results for Second-Quarter 2023 Resilient business line revenues drove performance as pullback in transaction activity continued into Q2 financial results second quarter jll reports 2023 https://www.biospace.com/cervomed-reports-fourth-quarter-and-full-year-2023-financial-results-and-provides-corporate-updates CervoMed Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Updates... Apr 1, 2024 - CervoMed Inc. (NASDAQ: CRVO), a clinical stage company focused on developing treatments for age-related neurologic disorders, today reported its financial... https://www.biospace.com/artelo-biosciences-reports-first-quarter-2023-financial-results-and-provides-business-update Artelo Biosciences Reports First Quarter 2023 Financial Results and Provides Business Update -... May 11, 2023 - Artelo Biosciences, Inc. today reported financial and operating results for the three months ended March 31, 2023 and provided a business update. first quarter 2023 financial https://www.globenewswire.com/de/news-release/2024/04/22/2866833/29606/en/Sify-reports-Consolidated-Financial-Results-for-FY-2023-24.html Sify reports Consolidated Financial Results for FY 2023-24 Revenue was INR 35,634 Million, an increase of 7% over last year. EBITDA was INR 6,756 Million, an increase of 7% over last year.... financial results fy 2023 sify reports consolidated https://www.biospace.com/vaxcyte-reports-first-quarter-2023-financial-results-and-provides-business-update Vaxcyte Reports First Quarter 2023 Financial Results and Provides Business Update - BioSpace May 8, 2023 - Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of... first quarter 2023 financial https://www.biospace.com/celcuity-inc-reports-third-quarter-2023-financial-results-and-provides-corporate-updates Celcuity Inc. Reports Third Quarter 2023 Financial Results and Provides Corporate Updates - BioSpace Nov 14, 2023 - Celcuity Inc., a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, reported financial results for the third quarter... https://investingnews.com/largo-reports-second-quarter-2023-financial-results-including-further-progress-on-its-cost-reduction-initiatives-and-commissioning-of-its-ilmenite-production-as-a-by-product-of-its-vanadium-operations/ Largo Reports Second Quarter 2023 Financial Results, Including Further Progress on its Cost... Aug 16, 2023 - All dollar amounts expressed are in thousands of U.S. dollars unless otherwise indicated. Q2 2023 and Other Highlights Revenues of $53.1 million vs. revenues... https://www.biospace.com/dermtech-reports-third-quarter-2023-financial-results DermTech Reports Third-Quarter 2023 Financial Results - BioSpace Nov 3, 2023 - DermTech, Inc., a leader in precision dermatology enabled by a non-invasive skin genomics technology, reported its third-quarter 2023 financial results. third quarter 2023 financial reports results https://www.globenewswire.com/fr/news-release/2023/11/08/2776683/0/en/rani-therapeutics-reports-third-quarter-2023-financial-results-provides-corporate-update.html Rani Therapeutics Reports Third Quarter 2023 Financial - Cash runway extended into 2025 - - Announced strategic program prioritization, expansion of manufacturing and plans to streamline business operations - ... third quarter rani therapeutics reports 2023 https://www.biospace.com/structure-therapeutics-reports-fourth-quarter-and-full-year-2023-financial-results-and-recent-highlights Structure Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Recent... Mar 8, 2024 - Structure Therapeutics Inc. today reported financial results for the fourth quarter and full year ended December 31, 2023, and highlighted recent corporate... fourth quarter https://www.arista.com/en/company/news/press-release/18437-pr-20231030 Arista Networks, Inc. Reports Third Quarter 2023 Financial Results - Arista SANTA CLARA, Calif.- October 30, 2023 -- Arista Networks, Inc. (NYSE: ANET), an industry leader in data-driven, client to cloud networking for large data... arista networks inc third quarter 2023 financial reports results https://www.biospace.com/xenon-pharmaceuticals-reports-first-quarter-2023-financial-results-and-provides-corporate-update Xenon Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Corporate Update -... May 10, 2023 - Xenon Pharmaceuticals Inc., a neurology-focused biopharmaceutical company, reported financial results for the first quarter ended March 31, 2023 and provided a... first quarter 2023 financial https://www.businesswire.com/news/home/20240307337790/en/Merrimack-Reports-Full-Year-2023-Financial-Results Merrimack Reports Full Year 2023 Financial Results Merrimack Reports Full Year 2023 Financial Results full year 2023 financial merrimack reports results https://www.biospace.com/sophia-genetics-reports-financial-results-for-the-third-quarter-of-fiscal-2023-record-results-on-growth-acceleration-significant-improvement-in-operating-loss-and-cash-burn SOPHiA GENETICS Reports Financial Results for the Third Quarter of Fiscal 2023 Record results on... Nov 8, 2023 - SOPHiA GENETICS SA, a cloud-native software company and a leader in data-driven medicine, reported financial results for the third quarter ended September 30,... https://www.seagate.com/sg/en/stories/articles/seagate-technology-reports-fiscal-first-quarter-2023-financial-results-pr/ Seagate Technology Reports Fiscal First Quarter 2023 Financial Results | Seagate Singapore seagate technology first quarter 2023 financial reports fiscal https://www.biospace.com/revance-reports-second-quarter-2023-financial-results-provides-corporate-update Revance Reports Second Quarter 2023 Financial Results, Provides Corporate Update - BioSpace Aug 9, 2023 - Revance Therapeutics, Inc. (RVNC), today reported financial results for the second quarter ended June 30, 2023 and provided a corporate update. second quarter 2023 financial corporate update revance reports https://www.prnewswire.com/news-releases/co-diagnostics-inc-reports-second-quarter-2023-financial-results-301898275.html Co-Diagnostics, Inc. Reports Second Quarter 2023 Financial Results /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular... second quarter 2023 financial diagnostics inc reports https://www.biospace.com/2seventy-bio-reports-fourth-quarter-and-full-year-2023-financial-results-and-recent-operational-progress 2seventy bio Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Operational... Mar 6, 2024 - 2seventy bio, Inc., a leading immuno-oncology cell therapy company, reported financial results and recent highlights for the fourth quarter and full year ended... https://www.biospace.com/clene-reports-third-quarter-2023-financial-results-and-operating-highlights Clene Reports Third Quarter 2023 Financial Results and Operating Highlights - BioSpace Nov 8, 2023 - Clene Inc. and its wholly owned subsidiary Clene Nanomedicine Inc. announced its third quarter 2023 financial results and provided recent operating highlights... third quarter 2023 financial reports https://www.seagate.com/stories/articles/seagate-technology-reports-fiscal-first-quarter-2023-financial-results-pr/ Seagate Technology Reports Fiscal First Quarter 2023 Financial Results | Seagate US seagate technology first quarter 2023 financial reports fiscal https://www.businesswire.com/news/home/20230808505833/en/Hippo-Reports-Second-Quarter-2023-Financial-Results Hippo Reports Second Quarter 2023 Financial Results Hippo (NYSE: HIPO), the home insurance group focused on proactive home protection, today announced its consolidated financial results for the three months th... second quarter 2023 financial hippo reports results https://www.businesswire.com/news/home/20230511005766/en/Kezar-Life-Sciences-Reports-First-Quarter-2023-Financial-Results-and-Provides-Business-Update Kezar Life Sciences Reports First Quarter 2023 Financial Results and Provides Business Update Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company discovering and developing breakthrough treatments for immune mediated and on... life sciences reports https://www.globenewswire.com/news-release/2024/03/20/2849756/0/en/HilleVax-Reports-Full-Year-2023-Financial-Results-and-Highlights-Recent-Company-Progress.html HilleVax Reports Full Year 2023 Financial Results and Topline data from NEST-IN1 Phase 2B clinical study of HIL-214 in infants expected in mid-2024 Enrollment for NEST-IN1 study completed in Q2 2023 ... full year 2023 financial reports results https://www.biospace.com/hanall-biopharma-reports-third-quarter-2023-financial-results-and-provides-a-business-update HanAll Biopharma Reports Third Quarter 2023 Financial Results and Provides a Business Update -... Oct 26, 2023 - HanAll Biopharma Co., Ltd. (KRX: 009420.KS), a global biopharmaceutical company committed to discovering and developing innovative medicines for patients,... https://www.businesswire.com/news/home/20231031620111/en/Allegion-NYSE-ALLE-Reports-Q3-2023-Financial-Results Allegion (NYSE: ALLE) Reports Q3-2023 Financial Results Allegion plc (NYSE: ALLE), a leading global security products and solutions provider, today reported financial results for its third quarter (ended Sept. 30,... alle reports q3 2023 allegion nyse financial